Phylo and Chugai collaborate to deploy AI platform in drug discoveryPharmaceutical Business Review·Aug 5 at 04:16 AMCHGCY-0.05%4519
Chugai seeks Japan approval for Enspryng to prevent MOGAD relapsesPUBT·Jul 31 at 01:32 AMCHGCY-0.05%4519
Chugai posts transcript of FY2026 Q2 financial results conference callPUBT·Jul 27 at 03:54 AMCHGCY-0.05%4519
Chugai Pharmaceutical : Double-digit revenue and profit growth driven by strong sales and robust pipeline progressQuartr·Jul 24 at 02:01 AMCHGCY-0.05%4519
Sobi tops bleeding disorder patient groups' reputation rankingsFiercepharma·Jul 10 at 03:17 AMNVO-1.17%RHHBY-1.41%
10:13 ETIDBS i3 2026 forum in Boston showcases real-world customer outcomes in data-driven BioPharmaprnewswire·Jun 4 at 09:14 AM45234519
Chugai Pharmaceutical (TSE:4519) Valuation In Focus After First Quarter 2026 Earnings ReleaseSimplywall·May 3 at 01:10 PM4519CHGCY-0.05%
Morning Trend | Chugai Pharmaceutical (ADR) rebounds after hitting a low, is a short-term rebound opportunity emerging?Technical Forecast·Apr 20 at 08:00 AMCHGCY-0.05%BBH-0.03%
Morning Trend | Chugai Pharmaceutical (ADR) reverses the downturn, has the reversal window opened?Technical Forecast·Apr 20 at 08:00 AMCHGCY-0.05%XLV-0.26%
Rani Therapeutics 2025 10-K: $1.63M revenue, $(0.45) EPSTradingView·Mar 26 at 03:45 PMPBE+0.07%RANI+1.04%
